Skip to main content
. 2020 Sep 1;9(9):2013. doi: 10.3390/cells9092013

Figure 5.

Figure 5

Synergistic inhibition of tumor xenografts by anticancer drugs with OxPhos inhibition. (A,C,E,G,I,K) Tumor volume measured using calipers. (B,D,F,H,J,L) Final weight of the subcutaneous tumors. (A, B) Colo 205 xenograft model with or without treatments (each group n = 3). (C,D) A375 xenograft model with or without treatments (n = 7). (E,F) SK-OV-3 xenograft model with or without treatments (n = 4). (G,H) PC-3 xenograft model with or without treatments (n = 4). (I,J) SNU-638 xenograft model with or without treatments (n = 5). (K,L) MIA PaCa-2 xenograft model with or without treatments (n = 5). Error bars represent the mean + s.d. *, p < 0.05; **, p < 0.01; ***, p < 0.001.